QuidelOrtho Corporation (QDEL) concluded trading on Wednesday at a closing price of $25.85, with 4.28 million shares of worth about $110.73 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.89% during that period and on May 07, 2025 the price saw a loss of about -0.35%. Currently the company’s common shares owned by public are about 67.30M shares, out of which, 66.11M shares are available for trading.
Stock saw a price change of -6.98% in past 5 days and over the past one month there was a price change of -8.85%. Year-to-date (YTD), QDEL shares are showing a performance of -41.98% which decreased to -39.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $23.77 but also hit the highest price of $49.45 during that period. The average intraday trading volume for QuidelOrtho Corporation shares is 1.19 million. The stock is currently trading -4.06% below its 20-day simple moving average (SMA20), while that difference is down -20.02% for SMA50 and it goes to -34.80% lower than SMA200.
QuidelOrtho Corporation (NASDAQ: QDEL) currently have 67.30M outstanding shares and institutions hold larger chunk of about 109.13% of that.
The stock has a current market capitalization of $1.74B and its 3Y-monthly beta is at 0.06. It has posted earnings per share of -$30.28 in the same period. It has Quick Ratio of 0.69 while making debt-to-equity ratio of 0.90. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for QDEL, volatility over the week remained 5.21% while standing at 6.38% over the month.
Analysts are in expectations that QuidelOrtho Corporation (QDEL) stock would likely to be making an EPS of 0.11 in the current quarter, while forecast for next quarter EPS is 0.74 and it is 3.25 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.01 which is 0.19 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.07 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 26.15% while it is estimated to increase by 39.48% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on December 11, 2024 offering a Buy rating for the stock and assigned a target price range of between $44 and $50 to it. Coverage by Jefferies stated QuidelOrtho Corporation (QDEL) stock as a Hold in their note to investors on December 10, 2024, suggesting a price target of $43 for the stock. On September 19, 2024, UBS Resumed their recommendations, while on September 05, 2024, Craig Hallum Upgrade their ratings for the stock with a price target of $57. Stock get a Sell rating from UBS on March 04, 2024.
